Alex d'Arbeloff named Chair of Whitehead Board of Directors

CAMBRIDGE, Mass. — Alex d’Arbeloff has been named Chair of the Board of Directors for Whitehead Institute for Biomedical Research. d’Arbeloff, former Chair of the MIT Corporation, founder of Teradyne, Inc. and current Professor of the Practice at MIT Sloan School of Management, succeeds Maxine Singer, President Emerita of the Carnegie Institution of Washington.

d’Arbeloff is best known for his role in founding Boston-based Teradyne, Inc. in 1960, a pioneer in the automated test equipment industry. During his tenure as CEO and Chair, Teradyne became an internationally recognized company and grew to $1.7 billion when d’Arbeloff stepped down as CEO in 1997.

d’Arbeloff has been a member of the MIT Corporation since 1989, and was Chair of the Corporation from 1997 to 2003, when he joined MIT Sloan School of Management where he teaches courses in innovation and leadership. He is currently an investor and director of several private companies in the Boston area and a director of Pegasystems, Inc. He is a fellow of the American Academy of Arts and Sciences and a director of the Isabella Stewart Gardner Museum. d’Arbeloff was recently honored by the International Institute of Boston with the Golden Door Award which celebrates a U.S. citizen of foreign birth who has made extraordinary contributions to American society. He has been a member of Whitehead Institute’s Board of Associates since 1997.

“Whitehead is very lucky to have Alex d'Arbeloff as Chair of the Board,” says former Chair Maxine Singer. “Alex is a tremendously talented leader, as evidenced by his remarkable career in industry, his leadership at MIT, and myriad contributions to the Boston health care community.”

“I am delighted to work with an organization that is making major contributions to biomedical research,” d’Arbeloff says.

Topics

Contact

Communications and Public Affairs
Phone: 617-452-4630
Email: newsroom@wi.mit.edu

Related News